We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
+6.62%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$111B
AUM Growth
+$10.5B
(+10%)
Cap. Flow
+$4.07B
Cap. Flow
% of AUM
3.67%
Top 10 Holdings %
Top 10 Hldgs %
16.5%
Holding
4,333
New
263
Increased
1,254
Reduced
2,016
Closed
548
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RAI
Reynolds American Inc
RAI
|
+$754M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$743M |
| 3 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$526M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$384M |
| 5 |
British American Tobacco
BTI
|
+$320M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cognizant
CTSH
|
+$308M |
| 2 |
AGN
Allergan plc
AGN
|
+$233M |
| 3 |
BATS
Bats Global Markets, Inc.
BATS
|
+$190M |
| 4 |
ACAS
American Capital Ltd
ACAS
|
+$186M |
| 5 |
SLB Ltd
SLB
|
+$142M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 11.15% |
| 2 | Technology | 9.78% |
| 3 | Healthcare | 9.21% |
| 4 | Consumer Discretionary | 6.76% |
| 5 | Consumer Staples | 6.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3476
Natera
NTRA
$36.4B
| $132K | ﹤0.01% |
14,879
-1,893
| -11% | -$18K |
|
3477
Costamare
CMRE
$1.85B
| $131K | ﹤0.01% |
19,671
-128,062
| -87% | -$778K |
|
|
CZZ
3478
DELISTED
Cosan Limited
CZZ
| $127K | ﹤0.01% |
14,847
-16,621
| -53% | -$139K |
|
|
TRVN
3479
DELISTED
Trevena, Inc.
TRVN
| $125K | ﹤0.01% |
55
-32
| -37% | -$109K |
|
|
CMCM
3480
Cheetah Mobile
CMCM
$87.2M
| $124K | ﹤0.01% |
+2,310
| New | +$120K |
|
3481
Ocular Therapeutix
OCUL
$1.83B
| $123K | ﹤0.01% |
13,262
-39,921
| -75% | -$332K |
|
3482
Aegon
AEG
$13.3B
| $121K | ﹤0.01% |
+30,689
| New | +$130K |
|
|
SMRT
3483
DELISTED
Stein Mart Inc
SMRT
| $121K | ﹤0.01% |
40,149
-7,304
| -15% | -$25.9K |
|
3484
STAAR Surgical
STAA
$1.19B
| $116K | ﹤0.01% |
11,830
-11,750
| -50% | -$117K |
|
3485
Arrowhead Research
ARWR
$12.1B
| $115K | ﹤0.01% |
61,803
-44,181
| -42% | -$87.6K |
|
|
HK.WS
3486
CALL
DELISTED
Halcon Resources Corporation
HK.WS
| $113K | ﹤0.01% |
64,173
| – | – |
|
3487
Liquidity Services
LQDT
$1.2B
| $112K | ﹤0.01% |
13,948
-28,078
| -67% | -$246K |
|
3488
United States Natural Gas Fund
UNG
$450M
| $111K | ﹤0.01% |
913
-855
| -48% | -$104K |
|
|
ZVO
3489
DELISTED
Zovio Inc. Common Stock
ZVO
| $111K | ﹤0.01% |
10,418
-7,929
| -43% | -$81.2K |
|
|
EMWP
3490
DELISTED
Eros Media World PLC
EMWP
| $111K | ﹤0.01% |
542
-987
| -65% | -$225K |
|
|
BSMX
3491
DELISTED
Banco Santander México, S, A., Institución de Banca Múltiple, Grupo Financiero Santander México
BSMX
| $106K | ﹤0.01% |
+11,782
| New | +$89.5K |
|
|
CVRR
3492
DELISTED
CVR Refining, LP
CVRR
| $104K | ﹤0.01% |
11,034
-558
| -5% | -$5.98K |
|
3493
Kopin
KOPN
$586M
| $102K | ﹤0.01% |
25,129
-15,950
| -39% | -$56.4K |
|
3494
LSB Industries
LXU
$824M
| $102K | ﹤0.01% |
14,006
-4,823
| -26% | -$33.3K |
|
3495
MannKind Corp
MNKD
$1.19B
| $102K | ﹤0.01% |
68,915
+9,551
| +16% | +$25.1K |
|
|
TTPH
3496
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $102K | ﹤0.01% |
553
-613
| -53% | -$68.7K |
|
|
ESIO
3497
DELISTED
Electro Scientific Industries
ESIO
| $100K | ﹤0.01% |
14,322
-7,486
| -34% | -$49.2K |
|
|
EVRI
3498
DELISTED
Everi Holdings
EVRI
| $99K | ﹤0.01% |
+20,790
| New | +$67.9K |
|
|
AMRN
3499
Amarin Corp
AMRN
$297M
| $98K | ﹤0.01% |
1,531
-2,392
| -61% | -$152K |
|
|
QHC
3500
DELISTED
Quorum Health Corporation
QHC
| $97K | ﹤0.01% |
17,850
-4,245
| -19% | -$34.6K |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q1 2017 Portfolio in Review
As of Q1 2017, Credit Suisse held 4,333 positions worth $111B, up 10% from $100B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Credit Suisse deployed $4.07B of net new capital in Q1 2017, opening 263 new positions and adding to 1,254 existing holdings. Its largest new stake was Qiagen: 1,270,687 shares worth $39M.
By sector, the portfolio is most concentrated in Financials at 11% of assets, down from 13% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Cognizant, an estimated $308M trimmed.
- Credit Suisse's largest Q1 2017 buy was Qiagen: 1,270,687 shares worth $39M.
- Credit Suisse added most to Reynolds American Inc in Q1 2017, an estimated $754M increase.
- Credit Suisse's biggest Q1 2017 reduction was Cognizant, cutting an estimated $308M.
- Credit Suisse fully exited Bats Global Markets, Inc. in Q1 2017, selling an estimated $190M.
- Credit Suisse's ten largest holdings make up 17% of its $111B portfolio in Q1 2017.
- Credit Suisse opened 263 new positions and closed 548 in Q1 2017.
- Credit Suisse's portfolio value rose 10% quarter-over-quarter to $111B.
Based on Credit Suisse's 13F filing for Q1 2017, filed 15 May 2017.